Condensed Consolidated Statements of Comprehensive Loss (Parenthetical) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Stock-based compensation | $ 6,414 | $ 6,238 | ||
| 541714 Research and Development in Biotechnology (except Nanobiotechnology) | ||||
| Stock-based compensation | $ 1,384 | $ 1,620 | 2,753 | 3,194 |
| Selling, General and Administrative Expenses | ||||
| Stock-based compensation | $ 1,952 | $ 1,575 | $ 3,661 | $ 3,044 |